| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.913.202 | 5.506.408 | 6.317.354 | 3.897.139 | 2.022.992 | 1.094.968 | 1.321.974 | 3.492.922 | 3.788.342 | 1.113.646 |
| Total Income - EUR | 4.185.889 | 5.707.296 | 6.408.316 | 3.935.649 | 2.024.367 | 1.133.813 | 1.383.021 | 4.872.785 | 4.393.304 | 1.184.020 |
| Total Expenses - EUR | 3.850.394 | 5.082.916 | 5.869.522 | 3.507.117 | 1.925.550 | 1.108.239 | 1.643.987 | 4.450.307 | 4.278.019 | 1.326.827 |
| Gross Profit/Loss - EUR | 335.496 | 624.380 | 538.794 | 428.532 | 98.818 | 25.574 | -260.965 | 422.478 | 115.285 | -142.807 |
| Net Profit/Loss - EUR | 281.816 | 524.479 | 442.593 | 359.967 | 83.007 | 21.482 | -260.965 | 354.881 | 96.840 | -141.601 |
| Employees | 6 | 6 | 6 | 6 | 5 | 6 | 5 | 4 | 5 | 0 |
Check the financial reports for the company - Escu Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 41.567 | 264.540 | 852.057 | 34.783 | 16.406 | 73.654 | 370.056 | 348.444 | 281.428 | 246.939 |
| Current Assets | 1.524.337 | 1.746.338 | 1.158.374 | 2.199.628 | 1.177.827 | 1.019.116 | 942.005 | 935.455 | 945.296 | 668.776 |
| Inventories | 92.371 | 94.353 | 169.369 | 1.660.519 | 381.342 | 561.895 | 258.909 | 217.036 | 177.199 | 102.535 |
| Receivables | 1.310.027 | 1.507.706 | 990.805 | 583.957 | 314.374 | 339.152 | 449.707 | 626.875 | 564.279 | 388.096 |
| Cash | 121.939 | 144.279 | -1.799 | -44.849 | 271.382 | 118.070 | 233.388 | 91.544 | 203.818 | 178.145 |
| Shareholders Funds | 281.870 | 524.533 | 442.646 | 360.019 | 83.057 | 21.532 | -260.917 | 93.155 | 96.888 | -141.553 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.286.477 | 1.488.764 | 1.567.786 | 1.874.392 | 1.111.177 | 1.071.238 | 1.572.978 | 1.190.744 | 1.129.835 | 1.057.267 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4100 - 4100" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Escu Pharm Srl